Shenzhen Chipscreen Biosciences Co., Ltd. (688321.SS)

CNY 19.97

(1.01%)

Operating Expenses Summary of Shenzhen Chipscreen Biosciences Co., Ltd.

  • Shenzhen Chipscreen Biosciences Co., Ltd.'s latest annual operating expenses in 2023 was 617.41 Million CNY , up 27.92% from previous year.
  • Shenzhen Chipscreen Biosciences Co., Ltd.'s latest quarterly operating expenses in 2024 Q2 was 154.61 Million CNY , up 23.18% from previous quarter.
  • Shenzhen Chipscreen Biosciences Co., Ltd. reported a annual operating expenses of 482.65 Million CNY in annual operating expenses 2022, up 22.68% from previous year.
  • Shenzhen Chipscreen Biosciences Co., Ltd. reported a annual operating expenses of 393.42 Million CNY in annual operating expenses 2021, up 66.46% from previous year.
  • Shenzhen Chipscreen Biosciences Co., Ltd. reported a quarterly operating expenses of 153.02 Million CNY for 2024 Q3, up 5.58% from previous quarter.
  • Shenzhen Chipscreen Biosciences Co., Ltd. reported a quarterly operating expenses of 125.51 Million CNY for 2024 Q1, down -17.3% from previous quarter.

Annual Operating Expenses Chart of Shenzhen Chipscreen Biosciences Co., Ltd. (2023 - 2016)

Historical Annual Operating Expenses of Shenzhen Chipscreen Biosciences Co., Ltd. (2023 - 2016)

Year Operating Expenses Operating Expenses Growth
2023 617.41 Million CNY 27.92%
2022 482.65 Million CNY 22.68%
2021 393.42 Million CNY 66.46%
2020 236.35 Million CNY 52.34%
2019 155.14 Million CNY 36.52%
2018 113.64 Million CNY 45.68%
2017 78 Million CNY -4.51%
2016 81.68 Million CNY 0.0%

Peer Operating Expenses Comparison of Shenzhen Chipscreen Biosciences Co., Ltd.

Name Operating Expenses Operating Expenses Difference
Hubei Jumpcan Pharmaceutical Co., Ltd. 4.61 Billion CNY 86.614%
Yabao Pharmaceutical Group Co., Ltd 1.43 Billion CNY 57.061%
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited 9.06 Billion CNY 93.19%
Harbin Pharmaceutical Group Co., Ltd. 3.39 Billion CNY 81.799%
Tasly Pharmaceutical Group Co., Ltd 4.56 Billion CNY 86.478%
Zhejiang Medicine Co., Ltd. 2.14 Billion CNY 71.204%
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited 2.52 Billion CNY 75.512%
Lionco Pharmaceutical Group Co.,Ltd. 235.93 Million CNY -161.686%
Humanwell Healthcare (Group) Co.,Ltd. 7.77 Billion CNY 92.06%
Ginwa Enterprise (Group) Inc. 473.93 Million CNY -30.273%
Joincare Pharmaceutical Group Industry Co.,Ltd. 6.84 Billion CNY 90.975%
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. 334.81 Million CNY -84.404%
China Animal Husbandry Industry Co., Ltd. 665.77 Million CNY 7.264%
Jiangsu Jibeier Pharmaceutical Co., Ltd. 516.66 Million CNY -19.5%
Zhejiang Huahai Pharmaceutical Co., Ltd. 3.89 Billion CNY 84.152%
Shanghai Haoyuan Chemexpress Co., Ltd. 720.84 Million CNY 14.349%
Ningbo Menovo Pharmaceutical Co., Ltd. 323.95 Million CNY -90.584%
Zhejiang Jiuzhou Pharmaceutical Co., Ltd 904.15 Million CNY 31.714%
Chongqing Taiji Industry(Group) Co.,Ltd 6.47 Billion CNY 90.458%
HPGC Renmintongtai Pharmaceutical Corporation 586.72 Million CNY -5.231%
Nanjing Well Pharmaceutical Group Co.,Ltd. 195.02 Million CNY -216.578%
Tianjin Tianyao Pharmaceuticals Co., Ltd. 1.58 Billion CNY 61.09%
Henan Lingrui Pharmaceutical Co., Ltd. 1.77 Billion CNY 65.133%
Guizhou Yibai Pharmaceutical Co., Ltd. 1.73 Billion CNY 64.475%
Jiangsu Kanion Pharmaceutical Co.,Ltd. 3.04 Billion CNY 79.748%
Zhongzhu Healthcare Holding Co.,Ltd 281 Million CNY -119.719%
Beijing Tongrentang Co., Ltd 5.21 Billion CNY 88.172%
KPC Pharmaceuticals, Inc. 2.88 Billion CNY 78.592%
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. 679.56 Million CNY 9.146%
North China Pharmaceutical Company Ltd. 3.05 Billion CNY 79.802%
China Resources Double-Crane Pharmaceutical Co.,Ltd. 4.1 Billion CNY 84.942%
Tibet Weixinkang Medicine Co., Ltd. 497.13 Million CNY -24.193%
China National Medicines Corporation Ltd. 1.04 Billion CNY 41.025%
Zhejiang Hisun Pharmaceutical Co., Ltd. 3.96 Billion CNY 84.423%
Heilongjiang ZBD Pharmaceutical Co., Ltd. 859.39 Million CNY 28.158%
ChengDu ShengNuo Biotec Co.,Ltd. 196.27 Million CNY -214.572%
Dali Pharmaceuticalco.,Ltd 56.92 Million CNY -984.524%
Changchun BCHT Biotechnology Co. 1.08 Billion CNY 43.21%
Zhejiang Shengda Bio-Pharm Co., Ltd. 119.2 Million CNY -417.937%
Shanghai Jiaoda Onlly Co.,Ltd 92.17 Million CNY -569.796%
Jiang Zhong Pharmaceutical Co.,Ltd 1.97 Billion CNY 68.707%
Mayinglong Pharmaceutical Group Co., LTD. 778.04 Million CNY 20.646%
Cisen Pharmaceutical Co., Ltd. 2.01 Billion CNY 69.358%
Hunan Warrant Pharmaceutical Co.,Ltd 691.12 Million CNY 10.665%
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. 17.16 Billion CNY 96.403%
Jianmin Pharmaceutical Group Co.,Ltd. 1.56 Billion CNY 60.645%
Hunan Fangsheng Pharmaceutical Co., Ltd. 912.55 Million CNY 32.343%
Guangxi Wuzhou Zhongheng Group Co.,Ltd 1.77 Billion CNY 65.123%
Guobang Pharma Ltd. 550.06 Million CNY -12.243%
Shaanxi Kanghui Pharmaceutical Co., Ltd. 245.55 Million CNY -151.438%
Kangmei Pharmaceutical Co., Ltd. 628.4 Million CNY 1.75%
Shandong Buchang Pharmaceuticals Co., Ltd. 8.48 Billion CNY 92.726%
Zhejiang Starry Pharmaceutical Co.,Ltd. 484.13 Million CNY -27.529%
Henan Taloph Pharmaceutical Stock Co.,Ltd 520.55 Million CNY -18.606%
ZhuZhou QianJin Pharmaceutical Co.,Ltd 1.28 Billion CNY 52.132%
Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd 2.19 Billion CNY 71.902%
Beijing Sun-Novo Pharmaceutical Research Co., Ltd. 334.18 Million CNY -84.75%
Shanghai Shyndec Pharmaceutical Co., Ltd. 3.54 Billion CNY 82.58%
Shanghai Yizhong Pharmaceutical Co., Ltd. 175.02 Million CNY -252.755%
Tibet Rhodiola Pharmaceutical Holding Co. 2.07 Billion CNY 70.268%
Sichuan Huiyu Pharmaceutical Co., Ltd. 672.26 Million CNY 8.159%
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. 249.26 Million CNY -147.694%
CanSino Biologics Inc. 1.49 Billion CNY 58.638%
Jiangsu Lianhuan Pharmaceutical Co., Ltd. 869.22 Million CNY 28.97%
Shandong Lukang Pharmaceutical Co.,Ltd. 1.18 Billion CNY 48.057%